Cowen Inc’s VivoSim Labs VIVS Stock Holding History

Cowen Inc’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-104	Closed	-$80K	–	353
2017 Q1	$80K	Hold	104	–	–	﹤0.01%	221
2016 Q4	$85K	Hold	104	–	–	﹤0.01%	231
2016 Q3	$95K	Sell	104 -159	-60%	-$156K	0.01%	219
2016 Q2	$234K	Buy	263 +21	+9%	+$14.1K	0.01%	189
2016 Q1	$126K	Sell	242 -8	-3%	-$4.07K	﹤0.01%	232
2015 Q4	$149K	Hold	250	–	–	0.01%	271
2015 Q3	$161K	Buy	+250	New	+$190K	0.01%	220

Other funds holding VIVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Cowen Inc's VIVS Position: Q2 2017 in Review

Cowen Inc sold out of VivoSim Labs (VIVS) in Q2 2017, closing a stake of 104 shares — an estimated $80K sold.

Cowen Inc first reported a position in VIVS in Q3 2015 and held it in 7 quarters. The position peaked at $234K in Q2 2016. 117 funds tracked by Wall St. Rank hold VIVS as of Q2 2017.

Cowen Inc reported no remaining VivoSim Labs position as of Q2 2017 after selling out during the quarter.
Cowen Inc sold 104 VivoSim Labs shares in Q2 2017, an estimated $80K.
Cowen Inc first reported a position in VivoSim Labs in Q3 2015 and held it in 7 quarters.
Cowen Inc's VivoSim Labs position peaked at $234K in Q2 2016.
117 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2017.

Based on Cowen Inc's 13F filing for Q2 2017, filed 10 Aug 2017.